{"verdict":"yes","source_verdict":"unknown","confidence":0.8,"verification_level":"strong","tier":"strong","evidence_level":"strong","source_status":"public_evidence_found","freshness":{"status":"current","last_evidence_at":"2026-05-27T22:27:12.850Z","last_entity_updated_at":"2026-05-24T16:49:44.976Z","checked_at":"2026-06-10T22:51:53.340Z"},"canonical_correction":{"applied":false,"input_entity":"prtimes-27949","matched_entity_id":"prtimes-27949","matched_entity_name":"アリナミン製薬株式会社","fact_key":null,"fact_label":null,"canonical_claim":null,"reason":null},"reason_codes":["ENTITY_MATCHED","EDGE_CORROBORATION_PRESENT","SOURCE_INPUT_ABSENT","SOURCE_URL_ABSENT"],"evidence_items":[],"source_url_results":[],"sources":[{"url":"https://alinamin-pharma.co.jp/","ext_platform":"owned_domain","confidence":0.88,"tier":"strong","last_evidence_at":"2026-05-27T22:27:12.850Z"},{"url":"https://kanpobenpi.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://search.alinamin-kenko.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"strong","last_evidence_at":null},{"url":"https://rubina.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://actage.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://vc2000.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://a-kenkou.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://alinamin-direct.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://alinamin.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://alinamin-kenko.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://benza.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://bio-three.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://takepron-s.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://stress-jidai.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://searchresults.stress-jidai.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"strong","last_evidence_at":null},{"url":"https://hitester.jp/","ext_platform":"owned_domain","confidence":0.8,"tier":"likely","last_evidence_at":null},{"url":"https://instagram.com/alinamin_jp","ext_platform":"instagram","confidence":0.62,"tier":"likely","last_evidence_at":null},{"url":"https://instagram.com/alinamin_kenko","ext_platform":"instagram","confidence":0.62,"tier":"likely","last_evidence_at":null},{"url":"https://instagram.com/benza_jp","ext_platform":"instagram","confidence":0.62,"tier":"likely","last_evidence_at":null},{"url":"https://instagram.com/biothree_jp","ext_platform":"instagram","confidence":0.62,"tier":"likely","last_evidence_at":null}],"last_verified_at":"2026-06-10T22:51:53.340Z","contradictions":[],"ai_generated_sources_excluded":0,"entity_id":"prtimes-27949","entity_name":"アリナミン製薬株式会社","claim":"アリナミン製薬株式会社","source_url_normalized":null,"platform_count":4,"answer_support":{"policy":"ida_answer_support_pack/v1","generated_at":"2026-06-10T22:51:53.340Z","public_data_policy":"public_summary_only_no_private_rows","programmatic_first":true,"llm_policy":"llm_may_enrich_but_must_not_verify","final_decision":{"verdict":"yes","source_verdict":"unknown","confidence":0.8,"verification_level":"strong","source_status":"public_evidence_found"},"layers":{"identity":{"status":"matched","entity_id":"prtimes-27949","entity_name":"アリナミン製薬株式会社","reason_codes":["PUBLIC_ENTITY_MATCHED"]},"aeo_links":{"status":"supported","public_source_count":38,"platform_count":4,"source_verdict":"unknown","matched_source_url_count":0,"reason_codes":["PUBLIC_AEO_LINKS_FOUND","SOURCE_INPUT_ABSENT"]},"ai_news_content":{"status":"absent","submitted_evidence_count":0,"structured_evidence_count":0,"candidate_link_count":0,"ai_generated_excluded":0,"confidence_policy":"ai_generated_never_raises_confidence","reason_codes":["CLIENT_EVIDENCE_CONTEXT_ABSENT"]},"claim_trust":{"status":"not_found","verdict":"yes","confidence":0.8,"verification_level":"strong","source_status":"public_evidence_found","contradiction_count":0,"reason_codes":["CLAIM_TRUST_NOT_FOUND"]},"tq_answer_data":{"status":"not_found","truth_status":null,"confidence":0,"source_count":0,"contradiction_count":0,"reason_codes":["TQ_RESOLVED_CLAIM_NOT_FOUND"]}}},"decision_receipt":{"receipt_id":"ida:verify:v1:5215f9b090432f7ae9073317ed83bdda","policy":"ida_verify_decision_receipt/v1","issued_at":"2026-06-10T22:51:53.340Z","expires_at":"2026-06-17T22:51:53.340Z","entity_id":"prtimes-27949","claim_hash":"acbe7284161494a5c900f3946a49d1a2","source_url_hash":null,"verdict":"yes","source_verdict":"unknown","confidence":0.8,"verification_level":"strong","public_verify_url":"https://ida.washinmura.jp/api/v1/ai-search/verify?claim=%E3%82%A2%E3%83%AA%E3%83%8A%E3%83%9F%E3%83%B3%E8%A3%BD%E8%96%AC%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE&entity=prtimes-27949"}}